Opinion article
sHLA-G production by human IVF embryos: Can it be measured reliably?

https://doi.org/10.1016/j.jri.2007.03.005Get rights and content

Abstract

A number of reports have demonstrated that sHLA-G can be detected in the culture medium of human IVF embryos and that levels correlate with the potential of an embryo to implant. This has aroused considerable interest in the IVF field. If sHLA-G can be used as a non-invasive marker of embryo quality, it will facilitate selection of the best embryos to transfer to the mother and thereby increase IVF pregnancy rates. However, there have been concerns about some aspects of these studies, including the sensitivity of the sHLA-G ELISAs used, the IVF culture conditions and the levels of sHLA-G which have been reported. A recent study by Sageshima et al. [J. Reprod. Immunol. 75, 11–22, 2007] attempts to address some of these concerns. However, despite using a sensitive ELISA, they were unable to detect sHLA-G in 111 embryo culture supernatants, or sHLA-G secretion by less than 10,000 sHLA-G transfected cells. They concluded that it is not possible to measure sHLA-G production by human embryos. This study has highlighted technical differences between IVF culture techniques and sHLA-G ELISAs that are currently confounding the system. Further collaboration between the research groups involved is required to establish robust reproducible systems that function identically in all laboratories.

Section snippets

Acknowledgements

The authors are members of “EMBIC”, a European Network of Excellence (http://www.embic.org) within the 6th Framework Programme of the European Union (LSHM-CT-2004-512040). They acknowledge the fruitful collaboration of many clinicians at ART Centres in Oxford, Poissy and Toulouse.

Cited by (32)

  • Noninvasive methods of embryo selection

    2018, Reproductomics: The -Omics Revolution and Its Impact on Human Reproductive Medicine
  • The effect of the biochemical marker soluble human leukocyte antigen G on pregnancy outcome in assisted reproductive technology - A multicenter study

    2013, Fertility and Sterility
    Citation Excerpt :

    There has been some criticism of the use of the optical density (OD) value as our sHLA-G unit value. It is interesting that no previous group reporting on applying an sHLA-G assay has reached a consensus on the appropriate way to report such results (22–25, 27, 29–33). We would like to report our results as an internationally agreed upon unit, but no such consensus exists.

  • Cumulative results including obstetrical and neonatal outcome of fresh and frozen-thawed cycles in elective single versus double fresh embryo transfers

    2010, Fertility and Sterility
    Citation Excerpt :

    Among them, the selection of the best oocytes by quantitative and qualitative analysis of spindle and zona retardance (36–38) and the metabolic profiling of oocytes and embryos (39–44) might be beneficial in the selection of oocytes and embryos with good developmental potential, leading to implantation, conception, and birth of a healthy child. Immunological biomarkers in individual follicular fluids and embryo supernatants should also help to assess the implantation potential of embryos (45, 46). Another approach for optimizing delivery rates after SET is to extend the embryo culture to day 5 and to transfer the embryo at the blastocyst stage (47).

  • Classical and non-classical Major Histocompatibility Complex class I gene expression in in vitro derived bovine embryos

    2009, Journal of Reproductive Immunology
    Citation Excerpt :

    The identification of a non-invasive marker of embryo developmental potential would allow clinical embryologists to select the best embryos for transfer, leading to higher IVF pregnancy rates and potentially a reduction in high risk multiple pregnancies. However, the issue of the sensitivity of the sHLA-G ELISAs has been raised (Sageshima et al., 2007) and explored in detail by Sargent et al. (2007), with the authors concluding that further collaboration between research groups is required to establish a more standardized and reproducible approach. In contrast to the situation in mice and humans, knowledge of the bovine MHC-I is relatively limited.

  • Soluble human leukocyte antigen-G and pregnancy success

    2008, Reproductive BioMedicine Online
View all citing articles on Scopus
View full text